Related Experiment Video

Updated: Dec 21, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.9K

Cardiovascular manifestation and treatment in COVID-19

Yen-Bo Su1,2, Ming-Jen Kuo1,2, Ting-Yu Lin1,2

  • 1Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.

Journal of the Chinese Medical Association : JCMA
|May 21, 2020
PubMed

Insights

Coronavirus disease 2019 (COVID-19) impacts the cardiovascular system, leading to severe outcomes in vulnerable patients. This review aids cardiologists in managing COVID-19 cardiovascular complications.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • The novel coronavirus disease 2019 (COVID-19) rapidly spread globally, causing significant mortality.
  • Vulnerable populations, including the elderly and those with pre-existing conditions like cardiovascular disease, diabetes, and chronic kidney disease, experience worse outcomes.
  • COVID-19 presents with atypical pneumonia and can directly affect the cardiovascular system.

Purpose of the Study:

  • To review the impact of COVID-19 on the cardiovascular system.
  • To assist clinical cardiologists in understanding and managing COVID-19 related cardiovascular complications.
  • To provide comprehensive medical support strategies for cardiologists on the frontline.

Main Methods:

  • This study is a review of existing literature on COVID-19 and its cardiovascular effects.
  • The review synthesizes information to provide a clinical overview for healthcare professionals.
  • Data from published studies and reports were analyzed.

Main Results:

  • COVID-19 infection is associated with direct cardiovascular injuries, including pericarditis, myocarditis, myocardial infarction, heart failure, arrhythmias, and thromboembolic events.
  • Patients with pre-existing cardiovascular conditions are at higher risk for severe COVID-19 outcomes.
  • Early identification and management of cardiovascular complications are crucial.

Conclusions:

  • Cardiologists play a critical role in managing patients with COVID-19, particularly those with cardiovascular risk factors or complications.
  • A thorough understanding of COVID-19's cardiovascular manifestations is essential for effective clinical practice.
  • Comprehensive medical support and timely intervention can improve outcomes for patients affected by COVID-19 and cardiovascular issues.

More Related Videos

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

1.1K
An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient07:16

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient

Published on: November 30, 2022

4.3K

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
239
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
287
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
115
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
329
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
277
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.9K